National Research Co. (NASDAQ:NRCIA) has received an average broker rating score of 3.00 (Hold) from the one brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a hold recommendation.
Zacks has also assigned National Research an industry rank of 111 out of 265 based on the ratings given to its competitors.
Several brokerages have weighed in on NRCIA. Zacks Investment Research raised National Research from a “sell” rating to a “hold” rating in a research report on Tuesday, February 6th. BidaskClub lowered National Research from a “buy” rating to a “hold” rating in a research report on Friday, January 19th.
In related news, CEO Michael D. Hays sold 1,602,399 shares of the stock in a transaction that occurred on Thursday, January 25th. The stock was sold at an average price of $39.03, for a total transaction of $62,541,632.97. Following the completion of the sale, the chief executive officer now owns 5,261,410 shares in the company, valued at approximately $205,352,832.30. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 37.54% of the stock is owned by corporate insiders.
Hedge funds have recently made changes to their positions in the business. Goldman Sachs Group Inc. lifted its position in shares of National Research by 55.6% in the 2nd quarter. Goldman Sachs Group Inc. now owns 19,467 shares of the business services provider’s stock worth $524,000 after acquiring an additional 6,955 shares during the period. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of National Research by 3.6% during the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 2,070,194 shares of the business services provider’s stock worth $78,046,000 after buying an additional 71,648 shares during the period. Teachers Advisors LLC lifted its position in shares of National Research by 36.6% during the 2nd quarter. Teachers Advisors LLC now owns 17,691 shares of the business services provider’s stock worth $476,000 after buying an additional 4,736 shares during the period. Citadel Advisors LLC bought a new position in shares of National Research during the 3rd quarter worth approximately $500,000. Finally, Strs Ohio lifted its position in shares of National Research by 49.6% during the 3rd quarter. Strs Ohio now owns 18,100 shares of the business services provider’s stock worth $682,000 after buying an additional 6,000 shares during the period. Institutional investors own 25.40% of the company’s stock.
About National Research
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.